Rockefeller Capital Management L.P. - AMICUS THERAPEUTICS INC ownership

AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 277 filers reported holding AMICUS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.

Quarter-by-quarter ownership
Rockefeller Capital Management L.P. ownership history of AMICUS THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$3
-100.0%
300
-69.4%
0.00%
Q3 2022$10,000
-16.7%
980
-13.0%
0.00%
Q2 2022$12,000
-7.7%
1,126
-19.2%
0.00%
Q1 2022$13,000
-45.8%
1,394
-35.1%
0.00%
Q4 2021$24,000
+140.0%
2,149
+87.7%
0.00%
Q3 2021$10,000
-9.1%
1,145
-5.7%
0.00%
Q2 2021$11,000
+1000.0%
1,214
+635.8%
0.00%
Q1 2021$1,000
-95.8%
165
-84.3%
0.00%
Q4 2020$24,000
-83.2%
1,048
-89.8%
0.00%
-100.0%
Q3 2020$143,000
+0.7%
10,239
+9.1%
0.00%0.0%
Q2 2020$142,000
+63.2%
9,381
-0.4%
0.00%0.0%
Q1 2020$87,000
-28.7%
9,414
-24.7%
0.00%
-50.0%
Q4 2019$122,000
+4.3%
12,500
-14.1%
0.00%0.0%
Q3 2019$117,000
-18.8%
14,550
+25.9%
0.00%0.0%
Q2 2019$144,000
+14300.0%
11,558
+18246.0%
0.00%
Q1 2019$1,000
-99.7%
63
-99.7%
0.00%
-100.0%
Q2 2018$299,000
+3.8%
19,1690.0%0.01%0.0%
Q1 2018$288,00019,1690.01%
Other shareholders
AMICUS THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Palo Alto Investors LP 10,524,022$127,972,10812.11%
Perceptive Advisors 27,692,917$336,745,87011.23%
Redmile Group, LLC 16,944,621$206,046,5919.80%
Finepoint Capital LP 1,489,025$18,106,5449.02%
CM Management, LLC 450,000$5,472,0005.81%
Avoro Capital Advisors LLC 27,400,000$333,184,0005.20%
MPM BioImpact LLC 716,139$8,708,2502.32%
Artal Group S.A. 4,062,567$49,4012.12%
SECTORAL ASSET MANAGEMENT INC 803,464$9,770,1221.90%
GREAT POINT PARTNERS LLC 857,000$10,421,1201.90%
View complete list of AMICUS THERAPEUTICS INC shareholders